| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.21B | 4.37B | 3.95B | 6.63B | 3.58B |
| Gross Profit | 4.41B | 2.01B | 336.00M | 6.57B | 3.07B |
| EBITDA | 626.00M | 574.00M | -1.32B | 4.88B | 2.17B |
| Net Income | 433.00M | 388.00M | -1.11B | 3.88B | 1.64B |
Balance Sheet | |||||
| Total Assets | 240.74B | 239.27B | 237.21B | 226.01B | 261.30B |
| Cash, Cash Equivalents and Short-Term Investments | 5.39B | 5.04B | 3.85B | 4.12B | 4.47B |
| Total Debt | 3.15B | 3.15B | 3.16B | 3.16B | 3.16B |
| Total Liabilities | 233.91B | 234.24B | 232.20B | 220.41B | 245.09B |
| Stockholders Equity | 6.77B | 4.96B | 4.94B | 5.46B | 16.14B |
Cash Flow | |||||
| Free Cash Flow | -102.00M | -290.00M | -137.00M | -1.23B | 746.00M |
| Operating Cash Flow | -102.00M | -290.00M | -137.00M | -1.23B | 746.00M |
| Investing Cash Flow | 164.00M | -2.19B | -3.20B | -8.28B | -12.24B |
| Financing Cash Flow | -108.00M | 3.68B | 3.07B | 9.14B | 11.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.06B | 12.11 | 6.05% | 2.91% | -4.58% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $3.41B | 15.89 | 2.86% | ― | 1.41% | 150.35% | |
63 Neutral | $6.77B | 6.10 | 12.27% | 3.93% | 35.76% | 636.97% | |
62 Neutral | $3.97B | 18.12 | 11.12% | 1.54% | -1.61% | 15.79% | |
58 Neutral | $7.44B | -334.28 | 0.27% | 2.98% | 24.94% | ― | |
54 Neutral | $3.54B | 10.47 | 7.38% | ― | 27.71% | ― |
On February 12, 2026, Brighthouse Financial stockholders held a virtual special meeting at which they approved a merger agreement under which an affiliate of Aquarian Capital LLC will acquire the insurer in an all-cash transaction valued at about $4.1 billion. Common stockholders will receive $70.00 in cash per share once the deal closes, with approximately 69.7% of outstanding shares represented at the meeting, and about 99.7% of votes cast in favor of the merger proposal.
Shareholders also passed an advisory proposal approving merger-related compensation for named executive officers and authorized potential adjournment of the meeting, though adjournment ultimately was not needed because sufficient votes were secured. The company said the transaction, which is expected to close in 2026 subject to customary conditions and regulatory approvals, marks a key step in its strategic transition under private ownership, with implications for investors who will be cashed out and for Aquarian Capital’s growing footprint in the U.S. life and annuity market.
The most recent analyst rating on (BHF) stock is a Hold with a $69.00 price target. To see the full list of analyst forecasts on Brighthouse Financial stock, see the BHF Stock Forecast page.